Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 100+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.



Our colleague Javier Aznárez from Business Development will be attending @Biospain2018 in Sevilla on the 25th to 27th September.
If you want to arrange a meeting there, contact us!

Idifarma will attend @CPhIWW 2018! Would you like to meet us there? Contact us at! #CPhIWW
More at

Idifarma tiene listo el pañuelico para el 6 de Julio ¡Felices fiestas de San Fermín! / Idifarma is ready for San Fermines tomorrow 6th of July! #Sanfermines2018

Pasado, presente y futuro de Idifarma, en @BiotechMagazine
El artículo completo aquí,

Idifarma participó, por primera, en el evento @vector_pharma celebrado en Ciudad de México en Junio. Ha sido una gran oportunidad para conocer mejor el mercado mexicano, y tratar posibles proyectos de colaboración.

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies